Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 5/20 | 0.53 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.46 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.46 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.44 |
| ▸ | AMY2A | P04746 | 3/20 | 0.43 |
| ▸ | FGF1 | P05230 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 4/20 | 0.43 |
| ▸ | CA1 | P00915 | 4/20 | 0.43 |
| ▸ | CA9 | Q16790 | 4/20 | 0.43 |
| ▸ | HPSE | Q9Y251 | 2/20 | 0.42 |
| ▸ | F10 | P00742 | 1/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29068320 | 1.00 | CA2 (0.53) | CA2LGALS8LGALS3LGALS4MAPT | |
| SCHEMBL9276971 | 1.00 | CA2 (0.53) | CA2LGALS8LGALS3LGALS4MAPT | |
| SCHEMBL4761249 | 1.00 | CA2 (0.53) | CA2LGALS8LGALS3LGALS4MAPT | |
| Cellobiose SCHEMBL15211052 | 0.99 | CA2 (0.52) | CA2LGALS8LGALS3LGALS4MAPT | |
| SCHEMBL30089360 | 0.95 | CA2 (0.50) | CA2LGALS8LGALS3LGALS4MAPT | |
| SCHEMBL30089438 | 0.95 | CA2 (0.49) | CA2LGALS8LGALS3LGALS4MAPT | |
| SCHEMBL26264978 | 0.91 | CA2 (0.47) | CA2LGALS8LGALS3LGALS4MAPT | |
| Cellobiose SCHEMBL4761241 | 0.88 | LGALS8 (0.54) | CA2LGALS8LGALS3LGALS4MAPT | |
| Maltose SCHEMBL9704098 | 0.86 | LGALS8 (0.53) | CA2LGALS8LGALS3LGALS4MAPT | |
| SCHEMBL25241935 | 0.85 | CA2 (0.47) | CA2LGALS3FGF1CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12630593-B2 | Method of killing leukemia cells by administration of recombinant'Y3 proteins | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2026-05-19 | — | — | US | disclosed |
| US-20230272019-A1 | FUNGAL GLYCAN BINDING PROTEIN WHICH POSSESSES ANTIVIRAL AND ANTICANCER ACTIVITY | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2023-08-31 | — | — | US | disclosed |
| US-11512119-B2 | Fungal glycan binding protein which possesses antiviral and anticancer activity | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2022-11-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630593-B2 | Method of killing leukemia cells by administration of recombinant'Y3 proteins | L3MBTL3, CHI3L1, BCL3 | CA2 3858/4885LGALS8 886/4885LGALS3 32/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.